Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma

Fibroblast growth factor-21 (FGF-21) improves insulin sensitivity and lipid metabolism in obese or diabetic animal models and has been proposed as a potential therapeutic agent for treating T2DM, obesity, and their related complications. However, little is known about the changes of FGF21 levels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xu, Yu, Haoyong, Yin, Jun, Li, Lianxi, Zhou, Jian, Li, Ming, Li, Qing, Chen, Haibing, Liu, Fang, Bao, Yuqian, Han, Junfeng, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320496/
https://www.ncbi.nlm.nih.gov/pubmed/28225059
http://dx.doi.org/10.1038/srep43123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320496/
https://www.ncbi.nlm.nih.gov/pubmed/28225059
http://dx.doi.org/10.1038/srep43123

Ejemplares similares